Ashley Rodriguez
NPI 1558064949 · Family Nurse Practitioner · Amarillo, TX
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1558064949
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Sex
- Female
- Sole proprietor
- No
- License
- 1112485 (TX)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Physician Assistants & Advanced Practice Nursing Providers
- Gerontology Nurse Practitioner363LG0600X
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
3 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Famotidine | 132 | 52 |
| Fluticasone Propionate | 87 | 57 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 82 | 51 |
| Montelukast Sodium | 76 | 25 |
| Levocetirizine Dihydrochloride | 58 | 27 |
| Epinephrine | 47 | 43 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$785 across 28 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2023-03-23
- Last updated
- 2023-05-15
- Certified
- 2023-05-15
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.